ABSTRACT
Background There are comparatively few international studies investigating suicide in military veterans and no recent UK studies. We aimed to investigate the rate, timing, and risk factors for suicide in personnel who left the UK Armed Forces (UKAF) over a 22-year period.
Methods and findings We conducted a retrospective cohort study of suicide in personnel who left the regular UKAF between 1996 and 2018 by linking national databases of discharged personnel and suicide deaths. Of the 458,058 individuals who left the UKAF, 1,086 (0.2%) died by suicide. The overall rate of suicide in veterans was not greater than the general population (SMR [95% CI] 94 [88-99]). However, suicide risk was two to four times higher in male and female veterans aged under 25 years than in the same age groups in the general population (age-specific mortality ratios ranging from 160 to 409). Male veterans aged 35 years and older were at reduced risk of suicide (age-specific mortality ratios 47 to 80). Male sex, Army service, discharge between the ages of 16 and 34 years, being untrained on discharge, and length of service under 10 years were associated with increased suicide risk. Factors associated with reduced risk included being married, a higher rank and deployment on combat operations. The rate of contact with specialist NHS mental health services (273/1,086, 25%) was lowest in the youngest age groups (10% for 16–19-year-olds; 23% for 20–24-year-olds).
Conclusions Suicide risk in veterans is not high but there are important differences according to age, with higher risk in young men and women. We found a number of factors which increased the risk of suicide but deployment was associated with reduced risk. Our focus should be on improving and maintaining access to mental health care and social supports for young service leavers, as well as implementing general suicide prevention measures for all veterans.
Competing Interest Statement
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: all authors had financial support from the Ministry of Defence (MOD) and NHS England, under MOD contract reference 700030303 for the submitted work; PT, LA and NK are contracted by the Healthcare Quality Improvement Partnership (HQIP) to deliver the Mental Health Clinical Outcome Review Programme (MHCORP); LA is Chair of the National Suicide Prevention Strategy Advisory Group (England), Department of Health and Social Care; NK is a member of the National Suicide Prevention Strategy Advisory Group (England), Department of Health and Social Care and a topic advisor for the National Institute for Health and Care Excellence (NICE) self-harm guidelines; no other relationships or activities that could appear to have influenced the submitted work.
Funding Statement
This study was jointly funded by the UK Ministry of Defence (MOD) and NHS England, MOD contract reference 700030303. Data have been provided by the Healthcare Quality Improvement Partnership (HQIP) from the Mental Health Clinical Outcome Review Programme delivered by the National Confidential Inquiry into Suicide and Safety in Mental Health (NCISH).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ministry of Defence Research Ethnics Committee (2071/MODREC/21) gave ethical approval for this work. Exemption under Section 251 of the NHS Act 2006, enabling access to confidential and identifiable information without informed consent in the interest of improving care, was obtained from the Health Research Authority Confidentiality Advisory Group (21/CAG/0050) and the Public Benefit and Privacy Panel for Health and Social Care (2021-0290). Data were provided by the Healthcare Quality Improvement Partnership (HQIP) from the Mental Health Clinical Outcome Review Programme (MH-CORP) delivered by the National Confidential Inquiry into Suicide and Safety (NCISH)(HQIP362).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data from this study cannot be shared because of information governance restrictions in place to protect confidentiality. Access to NCISH data can be requested via application to the Healthcare Quality Improvement Partnership (www.hqip.org.uk/national-programmes/accessing-ncapop-data/)
